The STEP trials demonstrated that participants lost an average of 10-15% of their body weight over 68 weeks, depending on lifestyle adherence and consistency with medication
Lowe Clayton said appetite suppression may also reduce consumption of foods that contain high amounts of water, including fruits and vegetables
Opportunities Growing Clinical Evidence of Cardiovascular and Renal Benefits is Creating Growth Opportunities Increasing clinical evidence highlighting the cardiovascular and renal benefits of certain GLP-1 receptor agonists is significantly driving their adoption
aAlbuminuria, chronic kidney disease, retinopathy, left ventricular hypertrophy, bAge (men 45 years, women 55 years), smoking, obesity, dyslipidemia, family history of early-onset coronary heart disease
Ive seen people lose weight, achieve their health goals, move more comfortably, feel more confident, and begin to believe in their health again